Print

Pipeline

Our vaccines in development.

PRODUCT INDICATION DEVELOPMENT PHASE COMMERCIAL RIGHTS
    1 2 3 4  
INFECTIOUS DISEASES
IMVAMUNE liquid-frozen * Smallpox         Bavarian Nordic
IMVAMUNE freeze-dried Smallpox         Bavarian Nordic
MVA-BN Filo monovalent ** Ebola         Janssen
MVA-BN Filo multivalent Ebola/Marburg         Janssen
MVA-BN RSV RSV         Bavarian Nordic
MVA-BN HPV Chronic HPV infection Preclinical development Janssen
CANCER IMMUNOTHERAPY
PROSTVAC monotherapy Prostate cancer (mCPRC)         Bristol-Myers Squibb
PROSTVAC combinations *** Prostate cancer         Bristol-Myers Squibb
CV301 + nivolumab Lung cancer         Bavarian Nordic
MVA-BN Brachyury Solid tumors         Bavarian Nordic


* Approved in the European Union under the trade name IMVANEX® and in Canada under the trade name IMVAMUNE®. Phase 3 registration studies are ongoing in the United States.
** Multiple Janssen-sponsored Phase 1, 2 and 3 clinical studies ongoing.
*** Multiple NCI-sponsored Phase 2 clinical studies ongoing.